InsidersTradesSigma
Track the Fluicell AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Fluicell AB has published 5 public disclosures. Market capitalisation: €49.5m. The latest transaction was filed on 9 March 2026 (Purchase). Among the most active insiders: Joakim Wahlberg. All data is free.
5
Insider Decl.
n/a
Thresholds
€31,947
5 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 March 2026
Declarations5 total
600 shares@ €1.02630.0015% mcap100.0% of flowAktieISIN SE0023595459FI:A003W850-1
1,000 shares@ €0.94150.0023% mcap100.0% of flowAktieISIN SE0023595459FI:A003U715-1
3,500 shares@ SEK 28.643100.0% of flowAktieISIN SE0010831321FI:A001P449-1
3,800 shares@ SEK 28.20100.0% of flowAktieISIN SE0010831321FI:A001P445-1
5 of 5 declarations
关于 Fluicell AB
Fluicell AB 是一家专注于开发生物医学研究技术的公司。它为细胞分析和组织生物学提供创新解决方案。